ASH HIGHLIGHTS 2024 – LEUKEMIA ROUNDTABLE DISCUSSIONS: Ivosidenib with Venetoclax Azacitidine in IDH1-Mutated Hematologic Malignancies
OR
Explore more from your favourite experts – click their name to access their entire library of content.
Chair
